Frank W. Larsen
Valby, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Pharmacokinetic modeling and simulation of a two-injection start with aripiprazole once-monthly in people living with schizophrenia: a plain language summary.
Journal: Current medical research and opinion
Published: November 01, 2025
Levels of aripiprazole in the blood with an injection of aripiprazole administered once every two months: a plain language summary of publication.
Journal: Therapeutic advances in psychopharmacology
Published: October 10, 2025
Exposure-Response Analysis for Aripiprazole Once-Monthly in Patients Diagnosed With Bipolar I Disorder.
Journal: Clinical pharmacology in drug development
Published: March 07, 2025
A review of clinical applications of pharmacokinetic simulations for a 2-month long-acting injectable formulation of aripiprazole.
Journal: Current medical research and opinion
Published: January 28, 2025
Plain Language Summary of Publication: A comparison of once-monthly and once-every-2-months injectable formulations of aripiprazole in people with schizophrenia.
Journal: Therapeutic advances in psychopharmacology
Published: March 23, 2024
Use of an injection of aripiprazole given once every 2 months (Abilify Asimtufii®) in people with bipolar I disorder: a Plain Language Summary of Publication.
Journal: Therapeutic advances in psychopharmacology
Published: March 23, 2024
Exposure-Response Modeling in Adults and Adolescents With Schizophrenia to Support the Extrapolation of Brexpiprazole Efficacy to Adolescents.
Journal: Journal of clinical pharmacology
Published: March 11, 2024
Randomized Phase I Trial of the α-Synuclein Antibody Lu AF82422.
Journal: Movement disorders : official journal of the Movement Disorder Society
Published: December 13, 2023
Population Pharmacokinetics and Dosing Simulations for Aripiprazole 2-Month Ready-to-Use Long-Acting Injectable in Adult Patients With Schizophrenia or Bipolar I Disorder.
Journal: Clinical pharmacology in drug development
Published: October 26, 2023
Pharmacokinetics and Safety of Eptinezumab in Healthy Chinese Participants: A Randomized Clinical Trial.
Journal: Clinical drug investigation
Published: October 04, 2023
Safety and Efficacy of Aripiprazole 2-Month Ready-to-Use 960 mg: Secondary Analysis of Outcomes in Adult Patients With Schizophrenia in a Randomized, Open-label, Parallel-Arm, Pivotal Study.
Journal: The Journal of clinical psychiatry
Published: September 06, 2023
Safety and efficacy of aripiprazole 2-month ready-to-use 960 mg: secondary analysis of outcomes in adult patients with bipolar I disorder in a randomized, open-label, parallel-arm, pivotal study.
Journal: Current medical research and opinion
Published: June 05, 2023
Last Updated: 09/26/2026